These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 17292950

  • 1. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.
    Petrucci E, Pasquini L, Petronelli A, Saulle E, Mariani G, Riccioni R, Biffoni M, Ferretti G, Benedetti-Panici P, Cognetti F, Scambia G, Humphreys R, Peschle C, Testa U.
    Gynecol Oncol; 2007 May; 105(2):481-92. PubMed ID: 17292950
    [Abstract] [Full Text] [Related]

  • 2. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.
    Lane D, Cartier A, L'Espérance S, Côté M, Rancourt C, Piché A.
    Gynecol Oncol; 2004 Jun; 93(3):594-604. PubMed ID: 15196850
    [Abstract] [Full Text] [Related]

  • 3. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
    Cuello M, Ettenberg SA, Nau MM, Lipkowitz S.
    Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
    [Abstract] [Full Text] [Related]

  • 4. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.
    Roa WH, Chen H, Fulton D, Gulavita S, Shaw A, Th'ng J, Farr-Jones M, Moore R, Petruk K.
    Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484
    [Abstract] [Full Text] [Related]

  • 5. Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs.
    Tomek S, Horak P, Pribill I, Haller G, Rössler M, Zielinski CC, Pils D, Krainer M.
    Gynecol Oncol; 2004 Jul; 94(1):107-14. PubMed ID: 15262127
    [Abstract] [Full Text] [Related]

  • 6. MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release.
    Mohr A, Büneker C, Gough RP, Zwacka RM.
    Oncogene; 2008 Jan 31; 27(6):763-74. PubMed ID: 17653087
    [Abstract] [Full Text] [Related]

  • 7. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
    Mori T, Doi R, Kida A, Nagai K, Kami K, Ito D, Toyoda E, Kawaguchi Y, Uemoto S.
    J Surg Res; 2007 Oct 31; 142(2):281-6. PubMed ID: 17640673
    [Abstract] [Full Text] [Related]

  • 8. High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide.
    Petronelli A, Saulle E, Pasquini L, Petrucci E, Mariani G, Biffoni M, Ferretti G, Scambia G, Benedetti-Panici P, Greggi S, Cognetti F, Russo MA, Sporn M, Testa U.
    Cancer Lett; 2009 Sep 18; 282(2):214-28. PubMed ID: 19364626
    [Abstract] [Full Text] [Related]

  • 9. Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells.
    Wahl H, Tan L, Griffith K, Choi M, Liu JR.
    Gynecol Oncol; 2007 Apr 18; 105(1):104-12. PubMed ID: 17174384
    [Abstract] [Full Text] [Related]

  • 10. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation.
    Checinska A, Hoogeland BS, Rodriguez JA, Giaccone G, Kruyt FA.
    Exp Cell Res; 2007 Apr 01; 313(6):1215-24. PubMed ID: 17291493
    [Abstract] [Full Text] [Related]

  • 11. Smac/DIABLO release from mitochondria and XIAP inhibition are essential to limit clonogenicity of Type I tumor cells after TRAIL receptor stimulation.
    Maas C, Verbrugge I, de Vries E, Savich G, van de Kooij LW, Tait SW, Borst J.
    Cell Death Differ; 2010 Oct 01; 17(10):1613-23. PubMed ID: 20395960
    [Abstract] [Full Text] [Related]

  • 12. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M, Strohecker A, Chen F, Kwan T, Bosman J, Jordan VC, Cryns VL.
    Clin Cancer Res; 2008 May 15; 14(10):3168-76. PubMed ID: 18483385
    [Abstract] [Full Text] [Related]

  • 13. A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death.
    Li L, Thomas RM, Suzuki H, De Brabander JK, Wang X, Harran PG.
    Science; 2004 Sep 03; 305(5689):1471-4. PubMed ID: 15353805
    [Abstract] [Full Text] [Related]

  • 14. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.
    Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Bhanot U, Hasel C, Möller P, Gschwend JE, Simmet T, Debatin KM, Fulda S.
    Cancer Res; 2009 Mar 15; 69(6):2425-34. PubMed ID: 19258513
    [Abstract] [Full Text] [Related]

  • 15. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
    Yang L, Mashima T, Sato S, Mochizuki M, Sakamoto H, Yamori T, Oh-Hara T, Tsuruo T.
    Cancer Res; 2003 Feb 15; 63(4):831-7. PubMed ID: 12591734
    [Abstract] [Full Text] [Related]

  • 16. Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.
    Horak P, Pils D, Kaider A, Pinter A, Elandt K, Sax C, Zielinski CC, Horvat R, Zeillinger R, Reinthaller A, Krainer M.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8585-91. PubMed ID: 16361541
    [Abstract] [Full Text] [Related]

  • 17. A small molecule SMAC mimic LBW242 potentiates TRAIL- and anticancer drug-mediated cell death of ovarian cancer cells.
    Petrucci E, Pasquini L, Bernabei M, Saulle E, Biffoni M, Accarpio F, Sibio S, Di Giorgio A, Di Donato V, Casorelli A, Benedetti-Panici P, Testa U.
    PLoS One; 2012 Dec 15; 7(4):e35073. PubMed ID: 22558117
    [Abstract] [Full Text] [Related]

  • 18. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
    Park SJ, Kim MJ, Kim HB, Sohn HY, Bae JH, Kang CD, Kim SH.
    Biochem Pharmacol; 2009 Apr 15; 77(8):1328-36. PubMed ID: 19426671
    [Abstract] [Full Text] [Related]

  • 19. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y, Harada K, Ferdous T, Yoshida H.
    Anticancer Res; 2007 Apr 15; 27(4B):2365-75. PubMed ID: 17695527
    [Abstract] [Full Text] [Related]

  • 20. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Gschwend JE, Simmet T, Debatin KM, Fulda S.
    Cancer Res; 2008 Oct 01; 68(19):7956-65. PubMed ID: 18829553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.